CEE PMSS (Central Eastern European Post-Marketing Surveillance Study) First Presentation of Mirapexin in Parkinson Patients.
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2014
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms CEE-PMSS
- Sponsors Boehringer Ingelheim
- 21 Nov 2009 Actual initiation date changed from Jan 2006 to Feb 2006 and actual patient number changed from 2324 to 2448 as reported by ClinicalTrials.gov.
- 27 Jan 2009 New trial record.